NO891273D0 - Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse. - Google Patents

Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse.

Info

Publication number
NO891273D0
NO891273D0 NO891273A NO891273A NO891273D0 NO 891273 D0 NO891273 D0 NO 891273D0 NO 891273 A NO891273 A NO 891273A NO 891273 A NO891273 A NO 891273A NO 891273 D0 NO891273 D0 NO 891273D0
Authority
NO
Norway
Prior art keywords
code
nucleic acid
acid sequences
growth factor
factor activity
Prior art date
Application number
NO891273A
Other languages
English (en)
Inventor
Joseph P Brown
Daniel R Twardzik
Hans Marquardt
George J Todaro
A Gregory Bruce
Timothy M Rose
Anthony F Purchio
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO891273D0 publication Critical patent/NO891273D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/485Epidermal growth factor [EGF], i.e. urogastrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
NO891273A 1988-03-24 1989-03-22 Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse. NO891273D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (1)

Publication Number Publication Date
NO891273D0 true NO891273D0 (no) 1989-03-22

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891273A NO891273D0 (no) 1988-03-24 1989-03-22 Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse.

Country Status (22)

Country Link
JP (1) JPH0279981A (no)
KR (1) KR890014743A (no)
AU (2) AU3169589A (no)
BE (1) BE1004202A5 (no)
CH (1) CH681081A5 (no)
DE (1) DE3910084A1 (no)
DK (1) DK146789A (no)
ES (1) ES2013408A6 (no)
FI (1) FI891308A (no)
FR (1) FR2632321A1 (no)
GB (1) GB2219799B (no)
GR (1) GR1000876B (no)
HU (1) HUT50501A (no)
IE (1) IE890950L (no)
IL (1) IL89673A0 (no)
IT (1) IT1234961B (no)
LU (1) LU87489A1 (no)
NL (1) NL8900724A (no)
NO (1) NO891273D0 (no)
NZ (1) NZ228427A (no)
PT (1) PT90118B (no)
SE (1) SE8901031L (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
CA2037440A1 (en) * 1990-03-02 1991-09-03 Gregory D. Plowman Her3: a novel egf receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
AU5549296A (en) * 1996-04-10 1997-10-29 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983004030A1 (en) * 1982-05-06 1983-11-24 Applied Molecular Genetics, Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (ja) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk 〔21―ロイシン〕ヒトウロガストロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (ja) * 1984-07-02 1996-11-13 アース製薬 株式会社 β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
ES2081801T3 (es) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co Plasmidos de expresion.
WO1989003886A1 (en) * 1987-10-30 1989-05-05 Oncogen, A Limited Partnership Expression systems for preparation of polypeptides in prokaryotic cells

Also Published As

Publication number Publication date
SE8901031D0 (sv) 1989-03-22
DE3910084A1 (de) 1989-11-16
SE8901031L (sv) 1989-09-25
FI891308A0 (fi) 1989-03-20
DK146789A (da) 1989-09-25
DK146789D0 (da) 1989-03-22
IT1234961B (it) 1992-06-09
IE890950L (en) 1989-09-24
ES2013408A6 (es) 1990-05-01
KR890014743A (ko) 1989-10-25
NZ228427A (en) 1993-03-26
PT90118A (pt) 1989-11-10
GB8906758D0 (en) 1989-05-10
GB2219799B (en) 1992-10-14
BE1004202A5 (fr) 1992-10-13
AU3169589A (en) 1989-09-28
NL8900724A (nl) 1989-10-16
FI891308A (fi) 1989-09-25
FR2632321A1 (fr) 1989-12-08
IT8919917A0 (it) 1989-03-24
CH681081A5 (no) 1993-01-15
IL89673A0 (en) 1989-09-28
JPH0279981A (ja) 1990-03-20
PT90118B (pt) 1994-07-29
GR890100185A (en) 1990-01-19
LU87489A1 (fr) 1989-10-26
AU2990492A (en) 1993-03-04
GR1000876B (el) 1993-03-16
HUT50501A (en) 1990-02-28
GB2219799A (en) 1989-12-20

Similar Documents

Publication Publication Date Title
NO892834L (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
DK446386D0 (da) Proteinhydrolysater, fremgangsmaader til fremstilling deraf og laegemidler, der indeholder disse hydrolysater
NO862545D0 (no) Vannbasert polymermateriale og fremgangsmaate til fremstilling, samt anvendelse derav.
DK385686D0 (da) Hybridplasminogenaktivator, vektorer og dna-enheder, som koder derfor samt aktivatorens anvendelse
DK4387A (da) Human-praepo-insulinlignende-vaekstfaktor i samt gener og syntetiske dna-sekvenser, som koder for denne
NO863765L (no) Arylmetylazoler og salter derav samt fremgangsmaate til fremstilling derav.
NO872174D0 (no) Polypetidpreparater med oekt biologisk tilgjengelighet.
DK188286D0 (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
NO891273D0 (no) Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse.
DK366589D0 (da) Humant protein c-mutant, dens fremstilling og dna, som koder derfor
DE3761451D1 (de) Kompressor mit frei-aussenliegender grundplatte und methode zum zusammenbau.
DK533087A (da) Anthracyklinglykosider, deres fremstilling, mellemprodukter deraf samt praeparater indeholdende disse og deres anvendelse
DE3689295D1 (de) Programmierbare Folgesteuerung.
NO905561D0 (no) Proteiner og nukleinsyrer.
NO892949D0 (no) Nye proteiner.
DK400786A (da) Udtrykkelsesvektorer til anvendelse i e. coli
NO862613L (no) Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for polypeptidene.
NO891274L (no) Nye polypeptider med vekstfaktoraktivitet og nukleinsyresekvenser som koder for disse.
DE3581939D1 (de) Verfahren zum prozessorsteuerkodespeichern, das kodeveraenderung zulaesst und adressierschaltung dafuer.
DK151788A (da) Hybridserpiner og dna, som koder derfor
NO873245D0 (no) Nye fosforbindelser og legemiddel inneholdende disse.
NO864209L (no) 13-alkyl-llbeta-fenyl-gonaner, og antikonsepsjonsmiddel inneholdende disse.
DK661389D0 (da) Dna-sekvens, som koder for placentaspecifikt protein pp11, dens isolering og anvendelse
SE8803443D0 (sv) Fusion protein possessing enzymatic activity and a nucleotide sequence coding for such fusion protein
NO882709L (no) Nye peptider og anvendelse derav.